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Abstract

Author Manuscript

Vascular cognitive impairment and dementia (VCID) is the second leading cause of dementia
behind Alzheimer’s disease (AD) and is a frequent co-morbidity with AD. Despite its prevalence,
little is known about the molecular mechanisms underlying the cognitive dysfunction resulting
from cerebrovascular disease. Astrocytic end-feet almost completely surround intraparenchymal
blood vessels in the brain and express a variety of channels and markers indicative of their
specialized functions in the maintenance of ionic and osmotic homeostasis and gliovascular
signaling. These functions are mediated by end-foot enrichment of the aquaporin 4 water channel
(AQP4), the inward rectifying potassium channel Kir4.1 and the calcium-dependent potassium
channel MaxiK.
Using our HHcy model of VCID we examined the time-course of astrocytic end-foot changes
along with cognitive and neuroinflammatory outcomes. We found that there were significant
astrocytic end-foot disruptions in the HHcy model. AQP4 becomes dislocalized from the end-feet,
there is a loss of Kir4.1 and MaxiK protein expression, as well as a loss of the Dp71 protein
known to anchor the Kir4.1, MaxiK and AQP4 channels to the end-foot membrane.
Neuroinflammation occurs prior to the astrocytic changes, while cognitive impairment continues
to decline with the exacerbation of the astrocytic changes.
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We have previously reported similar astrocytic changes in models of cerebral amyloid angiopathy
(CAA) and therefore, we believe astrocytic end-foot disruption could represent a common cellular
mechanism of VCID and may be a target for therapeutic development.
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Introduction
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Vascular contribution to cognitive impairment and dementia (VCID) is widely considered to
be the second most common cause of dementia after Alzheimer’s disease (AD), accounting
for 20–30 percent of cases (Levine and Langa, 2011). In addition, VCID occurs as a comorbidity with other common dementias including AD, where it is estimated to occur in as
many as 40% of all cases (Bowler et al., 1998, Kammoun et al., 2000, Langa et al., 2004,
Snyder et al., 2015). Over twenty years ago, hyperhomocysteinemia (HHcy) was identified
as an independent risk factor for stroke and vascular disease (Refsum et al., 1998). HHcy is
also associated with pathologically-confirmed VCID and AD (Clarke et al., 1998) and is
now accepted as a risk factor for AD (Beydoun et al., 2014). We have established a
hyperhomocysteinemia (HHcy) model of VCID in wildtype, C57BL6, mice. Dietary
induction of HHcy is achieved by the elimination of B6, B12 and folate from the diet and
enrichment with methionine (Troen et al., 2008). The mice develop cognitive impairment,
cerebral microhemorrhages and neuroinflammation in response to the diet (Sudduth et al.,
2013).

Author Manuscript

Astrocytes compose 50% of the cells of the brain and play several key roles in maintaining
the health of the neurons. In particular, they buffer potassium to regulate the excitability of
the neurons (Newman et al., 1984, Simard and Nedergaard, 2004, Wallraff et al., 2006). This
potassium buffering is also thought to contribute, at least in part, to the process of
neurovascular coupling; i.e., the process of matching local cerebral blood flow to the local
neuronal activity (Dunn and Nelson, 2010, Witthoft et al., 2013), however, the potassium
buffering role in neurovascular coupling remains disputed (Metea et al., 2007). To perform
the critical function of potassium buffering and osmotic homeostasis, astrocytes ensheath the
cerebrovasculature with specialized processes called end-feet. The astrocytic end-feet
express a variety of channels and markers indicative of their specialized functions in the
maintenance of ionic and osmotic homeostasis and gliovascular signaling (Simard and
Nedergaard, 2004). The channels enriched at the astrocytic end-feet are the aquaporin 4
water channel (AQP4) (Amiry-Moghaddam et al., 2003), the inward rectifying potassium
channel Kir4.1 (Butt and Kalsi, 2006) and the calcium-dependent potassium channel MaxiK
(also known as the BK channel) (Price et al., 2002). AQP4 and Kir4.1 are almost exclusively
expressed by astrocytic end-feet (Simard and Nedergaard, 2004). The MaxiK channel is
primarily in the astrocytic end-feet, with some expression by astrocyte processes that are not
associated with the vasculature (Farr and David, 2011).

Author Manuscript

We have previously shown that cererbral amyloid angiopathy (CAA) results in AQP4
dislocalization from the astrocytic end-foot, and loss of Kir4.1 and MaxiK channels. These
findings were observed in both the APPSwDI mouse model of CAA and human AD with
high CAA (Wilcock et al., 2009). In the current study we examine the astrocytic end-foot
markers in our HHcy mouse model of VCID along a time-course. We find that astrocytic
end-feet are significantly disrupted in the HHcy model. These changes are not apparent after
6 weeks of HHcy induction, but are after 10 weeks, and are significantly worse after 14
weeks of induction. Along a similar time-course, cognitive impairment is not observed until
10 weeks after HHcy induction, and performance is worse 14 weeks after HHcy induction.

Neuroscience. Author manuscript; available in PMC 2018 April 23.

Sudduth et al.

Page 3

Author Manuscript

Materials and Methods
Animals
Seventy-two C57BL6 wildtype mice aged 3 months were placed on diet with low levels of
folate, vitamins B6 and B12 and enriched with methionine (N=12/time-point) (Harlan
Teklad TD97345; Harlan Teklad, Madison, WI) or a control diet that nutritionally matched
the experimental diet with normal levels of methionine, folate, vitamins B6 and B12 (N=12/
time-point) (Harlan Teklad 5001C; Harlan Teklad, Madison, WI). Mice received diet for 6,
10 and 14 weeks. Mice were weighed weekly to ensure no significant malnourishment was
occurring due to the diet. The study was approved by the University of Kentucky
Institutional Animal Care and Use Committee and conformed to the National Institutes of
Health Guide for the Care and Use of Animals in Research.

Author Manuscript

Behavior testing
The two-day radial-arm water maze protocol was performed during the week prior to tissue
harvest as previously published (Alamed et al., 2006). Briefly, a six-arm maze was
submerged in a pool of water, and a platform was placed at the end of one arm (equipment
and tracking software from Noldus Information Technology Inc., Leesburg VA). Each mouse
received 15 trials per day for 2 days. The mouse began each trial in a different arm while the
arm containing the platform remained the same. The numbers of errors (incorrect arm
entries) were counted over a one-minute period. The errors were averaged over three trials,
resulting in 10 blocks for the two-day period (blocks 1–5 are day 1 while blocks 6–10 are
day 2).
Tissue processing and histology

Author Manuscript

After injection with a lethal dose of beuthanasia-D, blood was collected for plasma and the
mice were perfused intracardially with 25ml normal saline. Brains were rapidly removed
and bisected in the mid-sagittal plane. The left half was immersion fixed in 4%
paraformaldehyde for 24 hours, while the right half was dissected into anterior cerebral
cortex, posterior cerebral cortex, striatum, hippocampus, thalamus, cerebellum and rest of
brain. The posterior cerebral cortex and rest of brain were combined and immediately
homogenized in PBS for zymography (see detailed method below). The remaining pieces
were flash frozen in liquid nitrogen and stored at −80°C. The left hemibrain was passed
through a series of 10, 20 and 30% sucrose solutions as cryoprotection and 25μm frozen
horizontal sections were collected serially using a sliding microtome and stored floating in
PBS containing sodium azide at 4°C. Plasma samples were analyzed for Hcy levels by the
clinical laboratories of the University of Kentucky.
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Eight sections equally spaced 600mm apart were selected for free floating
immunohistochemistry for GFAP (Rat anti-GFAP, clone 2.2B10; Invitrogen, Camarillo, CA;
1:3,000), AQP4 (Rabbit polyclonal anti-AQP4; Millipore, Temecula, CA; 1:5,000) and Dp71
(Rabbit polyclonal anti-dystrophin 1, cross-reacting with Dp71; Abcam, Cambridge MA;
1:3,000). The method for free-floating immunohistochemistry has been described previously
(Wilcock et al., 2008). Sixteen sections equally spaced 300mm apart were mounted on slides
and stained for Prussian blue as described previously (Wilcock et al., 2004).
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Quantitative real-time RT-PCR
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RNA was extracted from the right hippocampus using the E.Z.N.A. Total RNA kit (Omega
Bio-Tek, Norcross, GA, USA) according to the manufacturer’s instructions. RNA was
quantified using the Biospec nano spectrophotometer (Shimaduz, Japan). cDNA was
produced using the cDNA High Capacity kit (ThermoFisher, Grand Island, NY, USA)
according to the manufacturer’s instructions. Real-time PCR was performed using the Fast
TaqMan Gene Expression assay (ThermoFisher, Grand Island, NY, USA). In each well of a
96-well plate, 0.5μL cDNA (100ng, based on the RNA concentrations) was diluted with
6.5μL RNase-free water. One microliter of the appropriate gene probe was added along with
10μL of Fast TaqMan to each well. Target amplification was performed using the ViiA7
(Applied Biosystems, Grand Island, NY, USA). All genes were normalized to 18S rRNA and
the fold change was determined using the −ΔΔCt method (Livak and Schmittgen, 2001).
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Western Blot
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Approximately 60mg of the brain powder was homogenized and protein lysates were
prepared in M-per lysis buffer (Thermo Scientific, Rockford, IL) containing 1% complete
protease/phosphatase inhibitor (Thermo Scientific, Rockford IL). Protein concentrations
were assessed using the BCA protein assay kit (Thermo Scientific, Rockford, IL), according
to manufacturer’s instructions. 15μg protein from each lysate was run on a denaturing 4–
20% SDS-PAGE gel. The gel was transferred onto a PVDF membrane using the iBlot
system (Invitrogen, Carlsbad CA), and Western blots were performed for Kir4.1 (Rabbit
polyclonal anti-Kir4.1; Millipore, Temcula, CA; 1:3,000) and MaxiK (Rabbit polyclonal
anti-MaxiK channel; Bioss, Wolburn, MA; 1:500). The blots were stripped using 5X New
Blot Nitro Stripping Buffer (Licor, Lincoln NE) and re-probed using the above protocol for
with β-actin as loading control (Rabbit monoclonal anti-b-actin, clone 13E5; Cell Signaling
Technology, Danvers, MA; 1:10,000). Semi-quantitative densitometry analysis was
performed using the Odyssey Imaging Software (Licor, Lincoln, NE). Individual
densitometry values were normalized to the β-actin densitometry value on the same blot.
Image analysis

Author Manuscript

Individuals who were blinded to the study, treatment groups and genotype of the animals
performed the image analysis. Images were collected using the Zeiss AxioScan slide
scanner. Frontal cortex and hippocampus were outlined maintaining uniformity through the
use of neuroanatomical landmarks. Eight sections for frontal cortex and between four and
six sections for hippocampus were analyzed per animal. To assess astrogliosis and
microgliosis, we examined frontal cortex, and the hippocampus for percent area occupied by
positive stain was analyzed using the Elements AR Image Analysis System (Nikon
Instruments, Melville, NY). To assess AQP4 and Dp71 staining, we counted the numbers of
vessels per region. A blinded investigator collected images in the same way as above,
however, this time, numbers of vessels were counted by manually clicking on vessels using
the same image analysis system. Eight sections for frontal cortex and 4–6 sections for
hippocampus were analyzed per animal.
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Statistical analysis
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Data are presented as mean ± standard error of mean (SEM). Statistical analysis was
performed using the JMP statistical analysis program (SAS, Cary NC). Radial-arm water
maze data and rotarod was analyzed by repeated measures ANOVA to assess overall effect
of diet. For the radial-arm water maze data, we also performed student’s t-test on individual
block data. For other data, one-way ANOVA and student’s t test were performed. Statistical
significance was assigned where the P-value was lower than 0.05.

Results

Author Manuscript
Author Manuscript

Elevated Hcy levels were achieved in all groups with no significant difference between the 6,
10 and 14 weeks on diet. The levels ranged from 60–105μmol/L with no difference between
any of the HHcy groups. The mice receiving the control diet all came in below the detection
range of the clinical laboratory assay, which is also a finding on the normal mouse chow of
our animal facilities. The two-day radial-arm water maze was performed immediately prior
to sacrifice. All mice, regardless of diet administration or duration of diet administration,
began the two days of testing making a high number of errors, as expected given all mice
were naïve to the task (figure 1A–C). After 6 weeks on diet, the HHcy and control mice
were virtually indistinguishable with the exception of block 8, where the HHcy mice made
significantly more errors than the control mice (figure 1A). Following 10 weeks of diet
administration, there are clear deficits in the two-day radial-arm water maze. The deficits are
mostly apparent on the second day. On the first block of day 2, the HHcy mice make
significantly more errors than the control mice, indicating a lack of consolidation between
days. Further, by the end of the second day the HHcy mice are still making significantly
more errors than the control mice (figure 1B). After 14 weeks of diet administration, HHcy
mice are significantly impaired across both days 1 and 2, indicating impairment in both
acquisition and consolidation (figure 1C).
We have previously shown that HHcy results in significant cerebrovascular pathology, as
evidenced by the occurrence of multiple microhemorrhages (Sudduth et al., 2013). In the
current study we find that microhemorrhage occurrence is dependent on duration of diet
administration. Microhemorrhages are apparent after only 6 weeks of diet administration,
but this is increased and shows statistical significance with 10 weeks of diet administration.
There is a further significant increase after 14 weeks of diet administration (figure 2). Across
the time-course of the current study we do not see any increase in the apparent size of the
microhemorrhages, but rather their numbers (examples of microhemorrhages are shown in
the images of figure 2).

Author Manuscript

In the current study, we focused on the astrocytes of the neurovascular unit, in particular, any
changes in the astrocytic end-foot markers that may indicate a dysfunctional neurovascular
unit. We first examined astrocytes by performing GFAP immunohistochemistry. There is no
apparent astrogliosis in response to HHcy, even after 14 weeks following diet administration,
where we see significant cerebrovascular pathology (figure 3).
AQP4 is a passive water channel that is highly polarized to the astrocytic end-foot.
Immunolabeling for AQP4 shows cerebrovascular labeling throughout the brain. Figure 4
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shows representative images of AQP4 immunolabeling of the frontal cortex of 14 weeks of
control diet administration (figure 4), or 6, 10 and 14 weeks of HHcy inducing diet
administration (figure 4). It is clear from the images that there is a decrease in AQP4
labeling of blood vessels with increasing duration of HHcy induction. We quantified the
numbers of AQP4 positive vessels immunolabeled. As can be seen from figure 4E, there is
no significant difference between control and HHcy with 6 weeks of diet administration,
however, AQP4 positive vessels are decreased in the frontal cortex and CA3 region of the
hippocampus of HHcy mice compared to control mice after 10 weeks of diet administration.
These same changes are apparent with 14 weeks of diet administration, however there is also
a significant decrease in AQP4 positive vessels in the CA1 region of the hippocampus as
well as the CA3 and the frontal cortex with 14 weeks of diet administration.

Author Manuscript

The Dp71 short form of dystrophin 1 is known as a key anchoring protein for the AQP4
channel (Connors and Kofuji, 2002, Amiry-Moghaddam et al., 2003). Immunolabeling for
Dp71 shows the same distribution as AQP4, with labeling of cerebral blood vessels (Figure
5). In mice on control diet for 14 weeks, there are numerous blood vessels labeled for Dp71
throughout the brain (frontal cortex shown in figure 5). Six weeks of diet administration to
induce HHcy does not significantly alter Dp71 expression as detected by immunolabeling
(figure 5). However, we found a significant decrease in blood vessel labeling with Dp71
after both 10 and 14 weeks of diet administration to induce HHcy (figure 5).

Author Manuscript

Co-anchored with the AQP4 channel, are the potassium channels Kir4.1 and the MaxiK
channel. These channels are crucial to the astrocyte function of potassium buffering. We
have quantified both the mRNA and protein levels of these two channels in the current study.
We found that gene expression levels of Kir4.1 were unchanged with 6 weeks of diet, but
decreased with 10 and 14 weeks of diet administration to induce HHcy (figure 6A).
Similarly, levels of MaxiK gene expression were also decreased at the 10 and 14-week time
points, but an intriguing significant increase in gene expression occurred at the 6-week timepoint (figure 6A). However, we observed an increase in MaxiK gene expression following 6
weeks of diet administration to induce HHcy (figure 6A). Protein expression of Kir4.1 and
MaxiK, as assessed by Western blot, showed similar reductions in expression with 10 and 14
weeks of diet administration to induce HHcy, but there was no change with only 6 weeks of
diet administration. The increase at the 6 week time-point in MaxiK gene expression did not
translate to an increase in protein expression (figure 6B and C).

Author Manuscript

Neuroinflammation is another phenomenon observed in our HHcy model. Microglial
activation, as measured by CD11b immunohistochemistry, is observed in HHcy mice and
this increase remains across all time-points examined, with no difference between the three
time-points studied (Figure 7). Pro-inflammatory mediators IL-1β, IL-6, IL-12 and TNFα
are all significantly increased in our HHcy model at all time-points studied (Figure 8).
However, the time-course of each is different. TNFα shows a steady state increase across all
time-points. However, IL-1β increases gradually over the time-points studied. IL-6 increased
quite sharply between the 10 and 14-week time-points. IL-12 appears to peak at the 10 week
time-point, however, due to the high variability there was no difference between any of the
time-points.
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Discussion
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VCID is the second most common cause of dementia behind AD. More critically, VCID is
also a frequent co-morbidity in sporadic AD cases, and also other dementias. Studies on
VCID have been hindered by the lack of animal models to study mechanistic underpinnings
of the vascular contribution to dementia. We have previously shown that CAA pathology is
associated with astrocytic end-foot dysfunction in AD and in CAA mouse models (Wilcock
et al., 2009). We hypothesized that astrocytic end-foot dysfunction may also be a key
pathological process in VCID. To test this we performed a time-course study in our HHcy
mouse model of VCID. This model reproduces aspects of VCID including
neuroinflammation, cognitive impairment and blood-brain barrier breakdown culminating in
microhemorrhages throughout the cerebral cortex and, less frequently, hippocampus
(Sudduth et al., 2013). In the current study, we examined mice on HHcy-inducing diet for a
period of 6, 10 and 14 weeks. We then did a careful histological and biochemical assessment
of astrocytic end-foot markers, as well as behavior and neuroinflammation.
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The cererbovasculature of the brain, primarily arterioles and capillaries, are almost
completely ensheathed by astrocytic processes called astrocytic end-feet. The astrocytic endfoot is a specialized unit that functions to maintain the ionic and osmotic homeostasis of the
brain. To perform this function, the end-feet are enriched with aquaporin 4 (AQP4) water
channels, as well as the potassium channels Kir4.1 and MaxiK (Newman et al., 1984,
Simard and Nedergaard, 2004, Bay and Butt, 2012). The anchoring proteins responsible for
maintaining these channels in the end-foot are the syntrophin-dystrophin 1 complex
(Connors and Kofuji, 2002, Amiry-Moghaddam et al., 2003, Amiry-Moghaddam et al.,
2004a, Amiry-Moghaddam et al., 2004b, Camassa et al., 2015). In the current study, HHcy
diet mice showed a reduction in DP71 labeling concurrent with reduced vascular labeling for
AQP4, and lower protein/mRNA levels for Kir4.1 and MaxiK potassium channels. These
observations suggest that HHcy leads to astrocyte end-feet disruption, which is likely to have
significant implications for both potassium homeostasis and neurovascular coupling.

Author Manuscript

The astrocytic end-foot is anchored to the vascular basement membranes via the α-β
dystroglycan complex (Noell et al., 2011, Gondo et al., 2014). Matrix metalloproteinase 9
(MMP9) (Michaluk et al., 2007), which shows high expression levels in astrocytes (ref?*),
appears to be a major degrading enzyme of the dystroglycans, specifically β-dystroglycan.
Because MMP9 is regulated through the neuroinflammatory response we examined the
neuroinflammatory state of the HHcy mice. We found microglial activation, as assessed by
CD11b immunohistochemistry, at all time-points examined, including the earliest, 6-week
time-point. While microglial activation remains elevated and steady across the time-course
studied, we found that the expression of pro-inflammatory mediators had different timecourses of changes. IL-1β and TNFα are known to be the primary regulators of MMP9
expression (Chakrabarti et al., 2006, Loesch et al., 2010, Klein and Bischoff, 2011). We
found that TNFα expression peaks at the earliest time-point examined; 6 weeks. While there
was a slight decline at the 10 and 14-week time-points, these changes were not significantly
lower than the 6-week expression and remained significantly elevated compared to the mice
on control diet. IL-1b showed a steady increase in expression over the time-course, with a
modest increase at the 6-week time-point, a significant increase at the 10 week time-point
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and a further increase at the 12-week time-point. Both IL-12 and IL-6 were also significantly
increased as a result of HHcy at all time-points examined. These data are consistent with our
previous reports of induction of a pro-inflammatory state by HHcy (Sudduth et al., 2013,
Sudduth et al., 2014). Given that neuroinflammation precedes the astrocytic changes and
cerebrovascular pathology it is possible that neuroinflammatory responses are key mediators
of these later pathologies.
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When we assessed cognition using the two-day radial water maze test of spatial memory, we
found that significant impairment was only apparent at the 10 and 14-week time-points, with
only one block of trials showing a deficit in the 6-week time-point. We can therefore
conclude that the presence of neuroinflammation alone, in the absence of cerebrovascular/
astrocyte pathologies or other changes we have examined, is insufficient to induce a
significant cognitive impairment. Only when other pathological events occur, specifically
microhemorrhages and astrocytic end-feet degeneration, do we see cognitive impairment.
While neuroinflammatory changes have been associated with cognitive impairment in the
past, this has typically been associated with sub-chronic administration of the potent
immune stimulator lipopolysaccharide (Semmler et al., 2007, Czerniawski et al., 2015, Sun
et al., 2015). The HHcy diet does not appear to generate as robust an inflammatory response
as that seen with LPS. However, based on our observations, we hypothesize that astrocytic
end-foot degeneration and blood-brain barrier leakage are downstream consequences of the
inflammatory response, and proximal causes of cognitive impairment.
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Potassium buffering is a key function of the astrocyte, and the astrocytic expression of
Kir4.1 and AQP4 at the end-foot is considered a critical component of this function. It has
been shown that deletion of the KCNJ10 gene, (Kir4.1), results in impaired potassium
buffering after synaptic activation and is associated with epilepsy (Haj-Yasein et al., 2011,
Larsen and MacAulay, 2014). AQP4 deletion is also associated with impaired potassium
buffering, likely through the altered osmotic balance (Strohschein et al., 2011). Cognitive
impairment worsens with increasing time on the HHcy-inducing diet. Only when the
astrocytic end-foot changes are present do we observe significant cognitive impairment in
the two-day radial arm water maze. We predict that it is impaired potassium buffering that is
mediating the cognitive impairment in the HHcy mouse model.
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In conclusion, our HHcy model of VCID shows significant astrocytic end-foot degeneration
including loss of the Dp71 anchoring protein, dislocalization of the AQP4 channel, and
decreased expression of the two key potassium channels Kir4.1 and MaxiK. These events
occur at the same time as cerebrovascular pathology is present. These events are preceded in
the time-course by a pro-inflammatory response in the brain and microglial activation.
Despite the early inflammatory response, cognitive impairment is only apparent when we
find astrocytic end-foot changes and cerebrovascular pathology. Intriguingly, the same
astrocytic changes were previously reported by ourselves in the CAA mouse model and in
human AD with CAA (Wilcock et al., 2009). We therefore hypothesize that astrocytic endfoot degeneration is a common pathological entity in VCID disorders. Future studies will
test this hypothesis in other VCID models and human samples.
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Figure 1. The two-day radial arm water maze task shows progressive cognitive deficits in HHcy
mice relative to mice on control diet

Panels A–C show mean number of errors per trial for mice receiving either control diet (red
lines) or HHcy-inducing diet (blue lines). Each block number is the average of errors for
three individual trials. Individual groups of mice were tested after being on diet for 6 weeks
(A), 10 weeks (B), and 14 weeks (C). * indicates P<0.05; ** indicates P<0.01 for the given
block comparison between mice on control diet for the same time.
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Figure 2. Microhemorrhages are increased in number after 10 and 14 weeks on HHcy inducing
diet

The images show representative Prussian blue positive microhemorrhages from either mice
on control diet for 14 weeks, or mice on HHcy inducing diet for 6, 10 and 14 weeks.
Microhemorrhages are shown as blue staining on the neutral red counterstained background.
The graph shows the mean number of microhemorrhages per section for each group of
animals. The mean is calculated from counts of 16 sections per animal. * indicates P<0.05;
** indicates P<0.01 when compared to mice on control diet for the same time.
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Figure 3. HHcy does not induce a significant astrogliosis in the brain

The images show representative GFAP immunohistochemistry in the dentate gyrus of the
hippocampus from either mice on control diet for 14 weeks, or mice on HHcy inducing diet
for 6, 10 and 14 weeks. The graph shows percent area occupied by GFAP-positive
immunostaining in the frontal cortex and hippocampus of mice receiving control diet (red
bars) or HHcy-inducing diet (blue bars).
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Figure 4. Astrocytic end-foot expression of AQP4 is significantly reduced following 10 and 14
weeks of HHcy-inducing diet

The images show representative AQP4 immunohistochemistry in the frontal cortex from
either mice on control diet for 14 weeks, or mice on HHcy inducing diet for 6, 10 and 14
weeks. The graph shows mean number of AQP4-positive vessels in the frontal cortex (FCX)
and hippocampus (CA3 and CA1 regions) of mice receiving control diet (red bars) or HHcyinducing diet (blue bars). * indicates P<0.05; ** indicates P<0.01 when compared to mice
on control diet for the same time.
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Figure 5. Astrocytic end-foot expression of Dp71 is significantly reduced following 10 and 14
weeks of HHcy-inducing diet

The images show representative Dp71 immunohistochemistry in the frontal cortex from
either mice on control diet for 14 weeks, or mice on HHcy inducing diet for 6, 10 and 14
weeks. The graph shows mean number of Dp71-positive vessels in the frontal cortex (FCX)
and hippocampus (CA3 and CA1 regions) of mice receiving control diet (red bars) or HHcyinducing diet (blue bars). ** indicates P<0.01 when compared to mice on control diet for the
same time.
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Figure 6. Expression of Kir4.1 and MaxiK is decreased after 10 and 14 weeks of HHcy induction

The hippocampus was used for gene expression analysis and the frontal cortex for the
protein analysis. The graph in A shows fold-change from the mice on control diet of Kir4.1
and MaxiK gene expression analysis by qPCR. The image in B show representative images
of Western blots for MaxiK, Kir4.1 and b-actin. These are the same samples for all 3 images.
The graph in C shows the quantification of band density for Kir4.1 and MaxiK normalized
to the density of the corresponding b-actin band. Each bar is the average of all animals for
each time-point. For graphs, * indicates P<0.05; ** indicates P<0.01 when compared to
mice on control diet for the same time.
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Figure 7. HHcy activates microglia at all time-points examined

The images show representative CD11b immunohistochemistry in the dentate gyrus of the
hippocampus from either mice on control diet for 14 weeks, or mice on HHcy inducing diet
for 6, 10 and 14 weeks. The graph shows percent area occupied by CD11b-positive
immunostaining in the frontal cortex and hippocampus of mice receiving control diet (red
bars) or HHcy-inducing diet (blue bars). * indicates P<0.05; ** indicates P<0.01 when
compared to mice on control diet for the same time.
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Figure 8. Pro-inflammatory mediators are increased by HHcy

qPCR analysis for TNFα, IL-1β, IL-12A and IL-6 was performed and the graphs show the
fold change at 6, 10 and 14 weeks relative to mice on control diet for the same amount of
time. * indicates P<0.05; ** indicates P<0.01 when comparing HHcy mice to mice on
control diet for the same time.
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